Intellectual Property News & Topics - Secerna LLP

WAKIX (1)

A to Z: Drugs in Highlight: W is for WAKIX®

News A to Z Feature 08/05/2025

Our A to Z series highlights WAKIX® (from Bioprojet Pharma) which is used to treat narcolepsy in adults, adolescents and children from 6 years of age. The active substance in WAKIX® is pitolisant. Pitolisant works by blocking histamine from attaching to the histamine H3 receptor on nerve cells.

Read more

NYE 2023 24

News 29/12/2023

How Intellectual Property Shapes New Year's Eve Shenanigans

Secerna Website Images 2023 (26)

Industry news, News 20/12/2023

UK Supreme Court Declares AI Can't Claim Patent Inventorship

Enlarged Board Of Appeal To Address Description Amendment Rules

European, Industry news, News 19/12/2023

Enlarged Board of Appeal to Address Description Amendment Rules

JP3 2551

European, News 13/12/2023

Secerna Receives Ongoing Recognition by International Rating Agency Leaders League

AI & Law (3)

Industry news, News 11/12/2023

High Court Breakthrough: Overturning UKIPO Decision Opens Doors for AI Patentability

Secerna Website Images 2023 (31)

European, Industry news, News 08/12/2023

Navigating the Future of European MedTech: Innovation Amidst Regulatory Hurdles

Secerna Website Images 2023 (5)

European, Industry news, News 05/12/2023

UK's £80 billion Horizon research programme association officially confirmed

Secerna Website Images 2023 (29)

Industry news, News 04/12/2023

Flooding and Intellectual Property: Protecting Both Tangible and Intangible Assets

Secerna Website Images 2023 (27)

European, News 28/11/2023

EPO Accelerates Opposition Proceedings for Infringement and Revocation

11 12 13 14 15 16 17 18 19 20 21